These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23147192)

  • 1. The changing face of hepatitis C in the new era of direct-acting antivirals.
    Soriano V; Labarga P; Fernández-Montero JV; Benito JM; Poveda E; Rallon N; Sánchez C; Vispo E; Barreiro P
    Antiviral Res; 2013 Jan; 97(1):36-40. PubMed ID: 23147192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behind.
    Ahmed F
    J Viral Hepat; 2013 May; 20(5):367-8. PubMed ID: 23565620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ; Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
    Zuckerman E; Safadi R; Oren R; Shibolet O; Baruch Y; Bruck R; Lurei Y; Kaspa RT; Abu-Mouch S; Shouval D; Ben-Ari Z;
    Harefuah; 2012 Dec; 151(12):709-14, 719. PubMed ID: 23330266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacotherapy for hepatitis C.
    Assis DN; Lim JK
    Clin Pharmacol Ther; 2012 Sep; 92(3):294-305. PubMed ID: 22850602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious diseases. First specific drugs raise hopes for hepatitis C.
    Enserink M
    Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
    [No Abstract]   [Full Text] [Related]  

  • 7. Directly acting antivirals against hepatitis C virus.
    Soriano V; Vispo E; Poveda E; Labarga P; Martin-Carbonero L; Fernandez-Montero JV; Barreiro P
    J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral agents and hepatitis C.
    Archer-Festa M; Nilsen-Kupsch S
    N Y State Dent J; 2012; 78(4):42-5. PubMed ID: 23252194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
    Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
    Welsch C; Jesudian A; Zeuzem S; Jacobson I
    Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-acting antiviral (DAA) actions in treatment-naïve patients.
    Hézode C
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S52-8. PubMed ID: 22248695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
    Rodríguez-Torres M
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1117-28. PubMed ID: 23199398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C].
    Sarrazin C; Berg T; Cornberg M; Dollinger M; Ferenci P; Hinrichsen H; Klinker H; Kraus M; Manns M; Mauss S; Peck-Radosavljevic M; Schmidt H; Spengler U; Wedemeyer H; Wirth S; Zeuzem S
    Z Gastroenterol; 2012 Jan; 50(1):57-72. PubMed ID: 22222799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and treatment of chronic hepatitis C in HIV patients.
    Barreiro P; Vispo E; Labarga P; Soriano V
    Semin Liver Dis; 2012 May; 32(2):138-46. PubMed ID: 22760653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
    Seden K; Back D
    Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2010 Jun; 65(6):1079-85. PubMed ID: 20335191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.
    Flemming JA; Terrault NA
    Infect Dis Clin North Am; 2012 Dec; 26(4):903-15. PubMed ID: 23083823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus resistance to protease inhibitors.
    Halfon P; Locarnini S
    J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of chronic hepatitis C in 2012 in Belgium].
    Moreno C; Deltenre P
    Rev Med Brux; 2012 Sep; 33(4):223-7. PubMed ID: 23091925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.